Q2 2024 Holdings
Filed 2024-08-14 | 38 holdings | $1.3B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-10-18) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $186.6M | 8,707,165 | 14.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $171.0M | 4,406,875 | 13.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $169.6M | 1,073,500 | 13.0% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $113.2M | 63,959,677 | 8.6% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $92.2M | 3,526,411 | 7.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $85.2M | 2,084,841 | 6.5% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $55.1M | 8,448,574 | 4.2% |
| Illumina Inc(ILMN) | COM | 452327109 | $50.1M | 480,000 | 3.8% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $44.8M | 2,000,000 | 3.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $41.3M | 170,000 | 3.2% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $35.2M | 326,378 | 2.7% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $30.2M | 1,300,000 | 2.3% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $27.5M | 700,000 | 2.1% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $27.5M | 650,000 | 2.1% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $20.9M | 6,732,971 | 1.6% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $19.1M | 524,616 | 1.5% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $18.6M | 857,904 | 1.4% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $16.8M | 800,000 | 1.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $15.8M | 675,000 | 1.2% |
| Verve Therapeutics Inc | COM | 92539P101 | $14.9M | 3,059,094 | 1.1% |
| Century Therapeutics Inc(IPSC)A | COM | 15673T100 | $13.2M | 5,190,506 | 1.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $10.8M | 1,000,000 | 0.8% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $10.2M | 1,188,349 | 0.8% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $7.7M | 2,000,000 | 0.6% |
| Codexis Inc(CDXS) | COM | 192005106 | $6.2M | 2,000,000 | 0.5% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $5.2M | 296,666 | 0.4% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $4.3M | 575,000 | 0.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.1M | 150,000 | 0.2% |
| Absci Corporation(ABSI) | COM | 00091E109 | $3.0M | 973,260 | 0.2% |
| Guardant Health Inc(GH) | COM | 40131M109 | $2.9M | 100,000 | 0.2% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $1.9M | 367,175 | 0.1% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $1.4M | 1,035,859 | 0.1% |
| Grail Inc(GRAL) | COM | 384747101 | $1.2M | 79,999 | 0.1% |
| Exscientia PLC | ADS | 30223G102 | $1.1M | 213,900 | 0.1% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $976.2K | 261,014 | 0.1% |
| Ginkgo Bioworks Holdings Inc(DNA4EUR) | CL A SHS | 37611X100 | $488.0K | 1,459,747 | 0.0% |
| Singular Genomics Systems in | COM NEW | 82933R308 | $372.9K | 44,129 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $153.6K | 123,839 | 0.0% |